No Detail Found!

An Evaluation of Anti- Alzheimer's Effect of Perindopril and Telmisartan in Scopolamine Induce Alzheimer's Disease in Rats

Author(s)
Fraz Khalid Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Anum Adil Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Sadaf Naeem Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan.
Anosh Tahir Dow Institute of Medical Technology, Dow University of Health Sciences, Karachi, Pakistan.
Maheen Zahidi Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Uzma Fraz Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Saira Saeed Khan Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Abstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-ß plaques, and tau tangles. Current therapies provide limited symptomatic relief and are often associated with adverse effects. This study aimed to evaluate the neuroprotective and cognitive-enhancing effects of perindopril and Telmisartan in a scopolamine-induced rat model of AD. Methods: Male Albino Wistar rats were randomly distributed to the following groups (n=6): Control, Negative control (Scopolamine only), Scopolamine + Perindopril, Scopolamine + Telmisartan, and Standard Group. Treatments were administered orally for 28 days. Cognitive function was assessed using the Morris Water Maze (MWM), Passive Avoidance Test (PAT), Elevated Plus Maze (EPM), and Novel Object Recognition (NOR) over five consecutive days. Acetylcholine (ACh) levels and acetylcholinesterase (AChE) activity were measured using the Amplex® Red Assay. Histopathological examination of brain tissue was performed to assess neurodegeneration. Results: Both perindopril and Telmisartan significantly reduced AChE activity and increased ACh levels compared to the scopolamine group (p<0.01), correlating with improved behavioral performance. Histological analysis confirmed reduced neuronal damage and gliosis in the treated groups. Conclusion: Perindopril and Telmisartan demonstrated neuroprotective and memory-enhancing effects in a scopolamine-induced AD model. Their ability to modulate the cholinergic system suggests potential utility as low-risk adjunct therapies for Alzheimer's disease.
Publication Details
Page(s) 163-172
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 3, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Neuroprotection, Antihypertensive Drugs, Telmisartan, Alzheimer's Disease, Memory enhancement, Perindopril
References
Scheltens P,Wiesje M. van der Flier P .2021 .Alzheimer's disease. The Lancet, 10284 : 1577-1590.
Qiu C,Kivipelto M.,Von Strauss E. .2009 .Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues in clinical neuroscience. , 11(2) : 111-28.
Sehar U,Rawat P,Reddy AP,Kopel J,Reddy PH .2022 .Amyloid beta in aging and Alzheimer's disease. International journal of molecular sciences, 23(21) : 12924.
Dunys J,Valverde A.,Checler F. .2018 .Are N-and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?. Journal of Biological Chemistry, 293(40) : 15419-28.
Dement A .2016 .Alzheimer's disease facts and figures. The Journal of the Alzheimer's Association, 12(4) : 459-509.
Azargoonjahromi A. .2024 .The duality of amyloid-β: its role in normal and Alzheimer's disease states. Molecular Brain, 17(1) : 44.
Breijyeh Z,Karaman R. .2020 .Comprehensive review on Alzheimer's disease:. Causes and treatment Molecules, 25(4) : 5789.
Cueto-Ureña C,Ramírez-Expósito MJ,Carrera-González MP,Martínez-Martos JM .2025 .Physiopathology of the Brain ReninAngiotensin System. Life, 15(8) : 1333.
Ababei DC,Bild V.,Macadan I.,Vasincu A.,Rusu R. N.,Blaj M.,Bild W. Therapeutic .2023 .Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.. Pharmaceutics, 15(9) : 2290.
Jeon S,Salvo MA,Alia AO,Popovic J,Zagardo M,Chandra S .2024 .Neuronal ACE1 knockout disrupts the hippocampal renin angiotensin system leading to memory impairment and vascular loss in normal aging. Neurobiology of Disease, 202 : 106729.
Jackson L,Eldahshan W,Fagan SC,Ergul A .2018 .Within the Brain: The Renin Angiotensin System. Int J Mol Sci, 19(3) : .
Sharma A,Rudrawar S,Bharate SB,Jadhav HR .2025 .Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective. RSC Medicinal Chemistry, 16(2) : 652-93.
Bild W,Vasincu A,Rusu R-N,Ababei D-C,Stana AB,Stanciu GD .2022 .Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases. Biomolecules, 12(10) : 1429.
Villapol S,Saavedra JM .2015 .Neuroprotective effects of angiotensin receptor blockers. American journal of hypertension, 28(3) : 289-99.
Zhou Z,Orchard SG,Nelson MR,Fravel MA,Ernst ME .2024 .Angiotensin receptor blockers and cognition: a scoping review. Current hypertension reports, 26(1) : 1-19.
Quan W,Zhang S-X,Zhang X-Y,Chen X,Yang C,Li Z-Y C .2025 .The application of telmisartan in central nervous system disorders. Pharmacological Reports, : 1-21.
Batool Z,Sadir S,Liaquat L,Tabassum S,Madiha S,Rafiq S .2016 .Repeated administration of almonds increases brain acetylcholine levels and enhances memory function in healthy rats while attenuates memory deficits in animal model of amnesia. , 120 : 63-74.
Khan GU,Khan SS,Naeem S,Awan AN,Siddiqui F,Siddiqui H,Insilico Study H .2025 .Leaf and Flower Extracts Improved Scopolamine-Induced Amnesia Via Regulation of Cholinergic Dysfunction and Brain Antioxidant Status: An In-vivo and. , 120141 : .
Naeem S,Ali L,Jaffar N,Khan SS,Shafiq Y,Suri S .2024 .Shark fish oil prevents scopolamine-induced memory impairment in an experimental model. , 39(1) : 15-27.
Liu Z,Kumar M,Kabra AJFiB-L. Cucurbitacin M .2022 .B exerts neuroprotection in a murine Alzheimer's disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. , 27(2) : 71.
Yasmin S,Ashique S,Taj T,Garg A,Das J,Shorog E .1850 .The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update. Brain Research, : 149400.
Petek B,Villa‐Lopez M,Loera‐Valencia R,Gerenu G,Winblad B,Kramberger M .2018 .Connecting the brain cholesterol and reninangiotensin systems: potential role of statins and RAS‐modifying medications in dementia. Journal of internal medicine, 284(6) : 620-42.
Aamir Mushtaq AM,Rukhsana Anwar RA .2018 .Lavandula stoechas (L) a very potent antioxidant attenuates dementia in scopolamine induced memory deficit mice. , : .
Gao Y,Li W,Liu Y,Wang Y,Zhang J,Li M .2018 .Effect of telmisartan on preventing learning and memory deficits via peroxisome proliferator-activated receptor-γ in vascular dementia spontaneously hypertensive rats. , 27(2) : 277-85.
Jafarian S,Ling KH,Hassan Z,Perimal‐Lewis L,Sulaiman MR,Perimal EK .2019 .Effect of zerumbone on scopolamine‐induced memory impairment and anxiety‐like behaviours in rats. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5(1) : 637-43.
Dhamal PV,Mate VH .2022 .A comparative evaluation of neuroprotective activity of perindopril and valsartan in rats. National Journal of Physiology, Pharmacy and Pharmacology, 12(10) : 1572.
Ouk M,Wu C-Y,Rabin JS,Jackson A,Edwards JD,Ramirez J .2021 .The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Alzheimer's Research & Therapy, 13 : 1-15.
Saeed AA,Harf MAEA,Bdeer SE,Elsherbini HA .2024 .A Study on the possible protective effects of angiotensin II type I receptor blocker (telmisartan) versus vitamin B12 on male albino rat model of Alzheimer. , 30(7) : 3540-52.
Rajesh V,Riju T,Venkatesh S,Babu G .2017 .Memory enhancing activity of Lawsonia inermis Linn. leaves against scopolamine induced memory impairment in Swiss albino mice. Oriental Pharmacy and Experimental Medicine, 17(2) : 127-42.
Mishra S,Pattanaik S,Sahoo S,Prusty SK,Sahu PK,Das D .2025 .New insights into repurposing of renin-angiotensin system inhibitors against Alzheimer's disease. Journal of Applied Pharmaceutical Science, 15(3) : 039-49.
Jawaid T,Jahan S,Kamal M. .2015 .A comparative study of neuroprotective effect of angiotensin converting enzyme inhibitors against scopolamine-induced memory impairments in rats. Journal of advanced pharmaceutical technology & research, 6(3) : 130-5.
Alzahrani YM,Sattar MAAA,Kamel FO,Ramadan WS,Alzahrani YA .2020 .Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats. Saudi Pharmaceutical Journal, 28(5) : 574-81.
Abbassi YA,Mohammadi MT,Foroshani MS,Sarshoori JR .2016 .Captopril and valsartan may improve cognitive function through potentiation of the brain antioxidant defense system and attenuation of oxidative/nitrosative damage in STZ-induced dementia in rat. Advanced pharmaceutical bulletin, 6(4) : 531.
Şen S,Hacıosmanoğlu EJC .2022 .Comparing the neuroprotective effects of telmisartan, perindopril, and nebivolol against lipopolysaccharide-induced injury in neuronlike cells. , 14(7) : .
0

Citations

0

Downloads

18

Views